Ryan D. Cassaday

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 769 citations · Full text

Medicine, Hematology, Oncology +9

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

Chand Khanna, Xiaolin Wan, Seuli Bose et al. · Nature Medicine · 2004 · 718 citations

Life Sciences, Cancer Biology, Cell Biology +12

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis

Adam M. Petrich, Mitul Gandhi, Borko Jovanovic et al. · Blood · 2014 · 466 citations

Medicine, Oncology, Hematologic Oncology +9

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

Kevin A. Hay, Jordan Gauthier, Alexandre V. Hirayama et al. · Blood · 2019 · 401 citations · Full text

Life Sciences, Immunology, Oncology +13

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

Alexandre V. Hirayama, Jordan Gauthier, Kevin A. Hay et al. · Blood · 2019 · 336 citations · Full text

Life Sciences, Immunology, Oncology +14